Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization- Fourier transform ion cyclotron resonance mass spectrometry

Analytical and Bioanalytical Chemistry

Volumn 406, Issue 18, 2014, Pages 4357-4370

  Guo, Shuai ^a   Qiu, Ling ^b   Wang, Yanming ^c   Qin, Xuzhen ^b   Liu, Hui ^a   He, Manwen ^a   Zhang, Yaping ^a   Li, Zhili ^a   Chen, Xiaohong ^d,e  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c Heze Municipal Hospital   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker panel; Lipids; Mass spectrometry imaging; Serum; Thyroid tumor; Y scatterplot

Indexed keywords

BIOMARKERS; BODY FLUIDS; DISEASES; HISTOLOGY; INDUCTIVELY COUPLED PLASMA; ISOTOPES; LIPIDS; MASS SPECTROMETRY; PHOSPHOLIPIDS; TUMORS;

FOURIER TRANSFORM ION CYCLOTRON RESONANCE MASS SPECTROMETRY; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; MASS-SPECTROMETRY IMAGING; MATRIX ASSISTED LASER DESORPTION; RECEIVER OPERATING CHARACTERISTIC CURVES; SERUM; THYROID TUMORS; Y-SCATTERPLOT;

DIAGNOSIS;

ACYL COENZYME A DESATURASE; BIOLOGICAL MARKER; FASN PROTEIN, HUMAN; FATTY ACID SYNTHASE; LIPID; SCD1 PROTEIN, HUMAN;

ADULT; AGED; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; CYCLOTRON; DIAGNOSTIC IMAGING; FEMALE; FOURIER ANALYSIS; HUMAN; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; RANDOMIZATION; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYCLOTRONS; DIAGNOSTIC IMAGING; FATTY ACID SYNTHASE, TYPE I; FEMALE; FOURIER ANALYSIS; HUMANS; LIPIDS; MALE; MASS SPECTROMETRY; MIDDLE AGED; RANDOM ALLOCATION; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STEAROYL-COA DESATURASE; THYROID GLAND; THYROID NEOPLASMS;

EID: 84903755922     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-014-7846-0     Document Type: Article

References (31)

1. Ito Y, Nikiforov YE, Schlumberger M, Vigneri R (2013) Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol 9:178-184
2. Anderson RT, Linnehan JE, Tongbram V, Keating K, Wirth LJ (2013) Clinical, safety, and economic evidence in radioactive iodine-refractory differentiated thyroid cancer: a systematic literature review. Thyroid 23:392-407
3. Lienart F (2012) Thyroid nodule: benign or malignant? Rev Med Brux 33:254-262
4. Carpi A, Rossi G, Nicolini A, Iervasi G, Russo M et al (2013) Does large needle aspiration biopsy add pain to the thyroid nodule evaluation? PLoS One 8:e58016
5. Cap J, Ryska A, Rehorkova P, Hovorkova E, Kerekes Z et al (1999) Sensitivity and specificity of the fine needle aspiration biopsy of the thyroid: clinical point of view. Clin Endocrinol (Oxf) 51:509-515
6. Sipos JA, Mazzaferri EL (2010) Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 22:395-404
7. Claudino WM, Quattrone A, Biganzoli L, Pestrin M, Bertini I et al (2007) Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol 25:2840-2846
8. Eberlin LS, Ferreira CR, Dill AL, Ifa DR, Cooks RG (2011) Desorption electrospray ionization mass spectrometry for lipid characterization and biological tissue imaging. Biochim Biophys Acta 1811:946-960
9. Santos CR, Schulze A (2012) Lipid metabolism in cancer. FEBS J 279:2610-2623
10. Gerbig S, Golf O, Balog J, Denes J, Baranyai Z et al (2012) Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging. Anal Bioanal Chem 403:2315-2325
11. Lee GK, Lee HS, Park YS, Lee JH, Lee SC et al (2012) Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type. Lung Cancer 76:197-203
12. Hilvo M, Denkert C, Lehtinen L, Muller B, Brockmoller S et al (2011) Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res 71:3236-3245
13. Tan B, Qiu Y, Zou X, Chen T, Xie G et al (2013) Metabonomics identifies serum metabolite markers of colorectal cancer. J Proteome Res 12:3000-3009
14. Lu J, Zhou J, Bao Y, Chen T, Zhang Y et al (2012) Serum metabolic signatures of fulminant type 1 diabetes. J Proteome Res 11:4705-4711
15. Guo Y, Wang X, Qiu L, Qin X, Liu H et al (2012) Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry. Clin Chim Acta 414:135-141
16. Li F, Qin X, Chen H, Qiu L, Guo Y et al (2013) Lipid profiling for early diagnosis and progression of colorectal cancer using direct-infusion electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun Mass Spectrom 27:24-34
17. Xuan J, Pan G, Qiu Y, Yang L, Su M et al (2011) Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res 10:5433-5443
18. Ganti S, Taylor SL, Abu Aboud O, Yang J, Evans C et al (2012) Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Cancer Res 72:3471-3479
19. Berry KA, Hankin JA, Barkley RM, Spraggins JM, Caprioli RM et al (2011) MALDI imaging of lipid biochemistry in tissues by mass spectrometry. Chem Rev 111:6491-6512
20. Norris JL, Caprioli RM (2013) Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. Chem Rev 113:2309-2342
21. Ishikawa S, Tateya I, Hayasaka T, Masaki N, Takizawa Y et al (2012) Increased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancer. PLoS One 7:e48873
22. Chughtai K, Heeren RM (2010) Mass spectrometric imaging for biomedical tissue analysis. Chem Rev 110:3237-3277
23. Zhang Y, Wang Y, Guo S, Guo Y, Liu H et al (2013) Ammonia-treated N-(1-naphthyl) ethylenediamine dihydrochloride as a novel matrix for rapid quantitative and qualitative determination of serum free fatty acids by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry. Anal Chim Acta 794:82-89
24. Dai W, Huang Q, Yin P, Li J, Zhou J et al (2012) Comprehensive and highly sensitive urinary steroid hormone profiling method based on stable isotope-labeling liquid chromatography-mass spectrometry. Anal Chem 84:10245-10251
25. Ide Y, Waki M, Hayasaka T, Nishio T, Morita Y et al (2013) Human Breast cancer tissues contain abundant phosphatidylcholine(36ratio1) with high stearoyl-CoA desaturase-1 expression. PLoS One 8:e61204
26. von Roemeling CA, Marlow LA, Wei JJ, Cooper SJ, Caulfield TR et al (2013) Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res 19:2368-2380
27. Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7:763-777
28. Maier T, Leibundgut M, Boehringer D, Ban N (2010) Structure and function of eukaryotic fatty acid synthases. Q Rev Biophys 43:373-422
29. Hori S, Nishiumi S, Kobayashi K, Shinohara M, Hatakeyama Y et al (2011) A metabolomic approach to lung cancer. Lung Cancer 74:284-292
30. Athenstaedt K, Daum G (1999) Phosphatidic acid, a key intermediate in lipid metabolism. Eur J Biochem 266:1-16
31. Segui B, Andrieu-Abadie N, Jaffrezou JP, Benoist H, Levade T (2006) Sphingolipids as modulators of cancer cell death: potential therapeutic targets. Biochim Biophys Acta 1758:2104-2120